Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
Marcela Safratova, Yu‐Li Chen, Anna Hostalkova, Jakub Chlebek, Chung‐Fan Hsieh, Bing‐Hung Chen, Lucie Cahlikova, Stefan Kosturko, Anders Backlund, Jim‐Tong Horng, Tsong‐Long Hwang, Michal KorinekABSTRACT
Background
Natural alkaloids are a structurally diverse class of bioactive compounds with significant therapeutic potential. This study aimed to evaluate the in vitro antiviral activity of various natural alkaloids against coronaviruses, clarify molecular effects via bioassays and docking, and explore structure–activity relationships. Tested compounds included a wide variety of isoquinoline and Amaryllidaceae‐type alkaloids.
Methodology
Antiviral activity was assessed using HCoV‐229E and pseudotyped lentivirus assays for different strains of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Cytotoxicity was evaluated with the WST‐1 assay. AutoDock was used for molecular docking, online tools assessed drug‐likeness, and ChemGPS‐NP analyzed physicochemical properties correlated to antiviral clinical drugs.
Results
Several bis‐benzylisoquinoline alkaloids, especially from
Conclusion
This study highlights the antiviral potential of bis‐benzylisoquinoline and Amaryllidaceae alkaloids, particularly aromoline. The findings support their relevance as scaffolds for developing novel anticoronavirus agents and advance the understanding of their structure–activity relationships.